Two medicines, side by side
Amitriptyline vs dopamine
Amitriptyline is labeled for depression; dopamine has no indication this site maps. Their labels share no use, so they are not alternatives to each other. Drugs@FDA records approvals of amitriptyline since 1961 and of dopamine since 1974. In FDA's classes, amitriptyline is a tricyclic antidepressant and dopamine a catecholamine.
Check it at the source: the amitriptyline FDA label on DailyMed (effective September 8, 2026); the dopamine FDA label on DailyMed (effective May 12, 2026).
Highlights of the amitriptyline record
Amitriptyline (Elavil) · label of September 8, 2026
Suicidality and Antidepressant Drugs: Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of amitriptyline hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.
Used for
From the label: indicationsFor the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.
On the market
- Earliest approval on file
- April 7, 1961
- Generic labelers
- 34 labelers
- Pharmacy cost
- $0.03 per tablet
Supply and safety
- Shortage
- No current entry
- Recalls
- 2
Highlights of the dopamine record
Dopamine (Intropin) · label of May 12, 2026
Used for
From the label: indicationsDopamine Hydrochloride in Dextrose Injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output. Dopamine HCl in Dextrose Injection is a catecholamine indicated to improve hemodynamic status in patients in shock.
On the market
- Earliest approval on file
- February 25, 1974
- Generic labelers
- 4 labelers
- Pharmacy cost
- Not in the survey
Supply and safety
- Shortage
- In shortage
- Recalls
- 2
Source: FDA drug labels via openFDA (Amitriptyline label of September 8, 2026, Dopamine label of May 12, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)
How do amitriptyline and dopamine differ on the record?
In FDA's classes, amitriptyline is a tricyclic antidepressant and dopamine a catecholamine.
How each works, in its label's words: Amitriptyline, “It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system.”; Dopamine, “Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA).”
Only the amitriptyline label carries a boxed warning.
Generics: amitriptyline since 1976; dopamine since 1985 (Drugs@FDA).
| Amitriptyline | Dopamine | |
|---|---|---|
| Labeled for | Depression | n/a |
| Pharmacologic class | Tricyclic Antidepressant | Catecholamine |
| How it works (label) | in man is not known. It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system. | Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). |
| Half-life (label) | n/a | Elimination The half-life of dopamine in adults is less than 2 minutes. |
| Earliest approval on file (Drugs@FDA) | April 7, 1961 | February 25, 1974 |
| First generic approved | November 16, 1976 | October 23, 1985 |
| Generic labelers (NDC) | 34 labelers | 4 labelers |
| Pharmacy cost (NADAC, each one's most listed form; strengths differ) | $0.03 per tablet (Amitriptyline HCl 10 mg tablet) | n/a |
| 12-month price change | -19% | n/a |
| Boxed warning | Yes | No |
| Shortage now | No current entry | In shortage |
| Recalls recorded | 2 | 2 |
| FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used) | 17,441 | 3,763 |
| DEA schedule | none | none |
Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)
Do their labels mention each other?
Dopamine label, drug interactionsTricyclic Antidepressants Clinical Impact: Concomitant use may potentiate the cardiovascular effects of dopamine (e.g., hypertension). Intervention: Monitor blood pressure. Examples: amitriptyline, desipramine, doxepin, imipramine, nortriptyline.
Source: FDA drug labels via openFDA
What do the labels say about using others of their kind?
Amitriptyline label, warningsIf concomitant use of amitriptyline hydrochloride with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John’s Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases.
Source: FDA drug labels via openFDA
What next?
- Alternatives to amitriptyline
- every medicine labeled for the same conditions